Education
About Us
Working with TipRanks
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
Total Valuation
Tonix Pharma has a market cap or net worth of $298.13M. The enterprise value is $138.80M.
Market Cap$298.13M
Enterprise Value$138.80M
Share Statistics
Tonix Pharma has 8,765,896 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,765,896
Owned by Insiders0.05%
Owned by Institutions0.07%
Financial Efficiency
Tonix Pharma’s return on equity (ROE) is -0.93 and return on invested capital (ROIC) is -92.40%.
Return on Equity (ROE)-0.93
Return on Assets (ROA)-0.80
Return on Invested Capital (ROIC)-92.40%
Return on Capital Employed (ROCE)-0.95
Revenue Per Employee124.62K
Profits Per Employee-1.61M
Employee Count81
Asset Turnover0.06
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Tonix Pharma is ―. Tonix Pharma’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.53
Price to FCF―
Price to Operating Cash Flow-3.64
PEG Ratio―
Income Statement
In the last 12 months, Tonix Pharma had revenue of 10.09M and earned -130.04M in profits. Earnings per share was -176.60.
Revenue10.09M
Gross Profit2.33M
Operating Income-136.70M
Pretax Income-130.04M
Net Income-130.04M
EBITDA-126.61M
Earnings Per Share (EPS)-176.60
Cash Flow
In the last 12 months, operating cash flow was -64.84M and capital expenditures -545.00K, giving a free cash flow of -65.39M billion.
Operating Cash Flow-64.84M
Free Cash Flow-65.39M
Free Cash Flow per Share-7.46
Dividends & Yields
Tonix Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change25.85%
50-Day Moving Average41.36
200-Day Moving Average27.58
Relative Strength Index (RSI)37.57
Average Volume (3m)1.99M
Important Dates
Tonix Pharma upcoming earnings date is Nov 10, 2025, TBA (Confirmed).
Last Earnings DateAug 11, 2025
Next Earnings DateNov 10, 2025
Ex-Dividend Date―
Financial Position
Tonix Pharma as a current ratio of 6.50, with Debt / Equity ratio of 0.29%
Current Ratio6.50
Quick Ratio6.04
Debt to Market Cap0.10
Net Debt to EBITDA0.72
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Tonix Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tonix Pharma EV to EBITDA ratio is 0.13, with an EV/FCF ratio of 0.26.
EV to Sales-1.59
EV to EBITDA0.13
EV to Free Cash Flow0.26
EV to Operating Cash Flow0.26
Balance Sheet
Tonix Pharma has $125.33M in cash and marketable securities with $492.00K in debt, giving a net cash position of -$124.84M billion.
Cash & Marketable Securities$125.33M
Total Debt$492.00K
Net Cash-$124.84M
Net Cash Per Share-$14.24
Tangible Book Value Per Share$61.60
Margins
Gross margin is 29.27%, with operating margin of -1354.28%, and net profit margin of -1288.25%.
Gross Margin29.27%
Operating Margin-1354.28%
Pretax Margin-1288.25%
Net Profit Margin-1288.25%
EBITDA Margin-1254.36%
EBIT Margin-1288.25%
Analyst Forecast
The average price target for Tonix Pharma is $58.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$58.67
Price Target Upside82.32% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-21.09%
EPS Growth Forecast90.95%